Top compounds associated with response to CHFR


Feature Type Standardized
Nominal ANOVA
mRNA Roscovitine FIMM pan-cancer AAC -0.22 0.2
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.044 0.2
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.071 0.2
mRNA DBeQ CTRPv2 pan-cancer AAC 0.048 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA thapsigargin gCSI pan-cancer AAC -0.075 0.2
mRNA etoposide GDSC1000 pan-cancer AAC -0.045 0.2
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.045 0.2
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.044 0.2
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.045 0.2
Download CSV